ENSILICATED TECHNOLOGIES LTD

Active Bristol

Research and experimental development on biotechnology

12 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

ENSILICATED TECHNOLOGIES LTD

Research and experimental development on biotechnology

Founded 29 Jul 2021 Active Bristol, England 12 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Apr 2026 8 days remaining
Confirmation
Net assets £451K £282K 2024 year on year
Total assets £652K £92K 2024 year on year
Total Liabilities £201K £190K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Science Creates St Philips Albert Road St. Philips Bristol BS2 0XJ England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ENSILICATED TECHNOLOGIES LTD (13537400), an active life sciences and medical technology company based in Bristol, England. Incorporated 29 Jul 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£363.06k

Decreased by £228.08k (-39%)

Net Assets

£451.13k

Decreased by £282.37k (-38%)

Total Liabilities

£200.88k

Increased by £189.97k (+1742%)

Turnover

N/A

Employees

12

Increased by 6 (+100%)

Debt Ratio

31%

Increased by 30 (+3000%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 5Jan 2023Pre-Seed
Investor 6Jan 2023Pre-Seed
Investor 7Jan 2023Pre-Seed

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 877,458 Shares £4.66m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
8 Aug 2025220,556£1.27m£5.78
8 Aug 2025483,364£2.79m£5.78
8 Aug 202520,051£116k£5.78
29 May 2025142,928£325k£2.274
19 Dec 2022659£150k£227.38

Officers

Officers

2 active 1 resigned
Status
Alexander Michael FinkDirectorBritishEngland3919 Dec 2022Active
Sarah Jane PollittDirectorBritishEngland586 Dec 2023Active

Shareholders

Shareholders (22)

Qantx Ltd Nominee
15.0%
228,768
Asel Sartbaeva
14.1%
214,400

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Aswin Doekhie

Ceased 20 Jul 2022

Ceased

Asel Sartbaeva

Ceased 20 Jul 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Feb 2026OfficersTermination of Sarah Jane Pollitt as director on 2026-01-19
28 Oct 2025OfficersAppointment of Mr Nicholas John Maishman as director on 2025-09-01
28 Oct 2025OfficersAppointment of Mr Timothy Jason Sparey as director on 2025-09-01
10 Sept 2025IncorporationMemorandum Articles
10 Sept 2025ResolutionResolutions
4 Feb 2026 Officers

Termination of Sarah Jane Pollitt as director on 2026-01-19

28 Oct 2025 Officers

Appointment of Mr Nicholas John Maishman as director on 2025-09-01

28 Oct 2025 Officers

Appointment of Mr Timothy Jason Sparey as director on 2025-09-01

10 Sept 2025 Incorporation

Memorandum Articles

10 Sept 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Termination of Sarah Jane Pollitt as director on 2026-01-19

2 months ago on 4 Feb 2026

Appointment of Mr Nicholas John Maishman as director on 2025-09-01

5 months ago on 28 Oct 2025

Appointment of Mr Timothy Jason Sparey as director on 2025-09-01

5 months ago on 28 Oct 2025

Memorandum Articles

7 months ago on 10 Sept 2025

Resolutions

7 months ago on 10 Sept 2025